Fed officials are likely to indicate on Wednesday that the economy remains "firm enough" and that there is no need to do anything until the outcomes of policies from Washington become clear, according ...

Sarepta Therapeutics' shares have struggled for the past year due to concerns about the commercial potential of its gene therapy and broader pipeline. Safety hadn’t been a major worry for investors—pa ...